Share based payment |
a)Replacement of Group Stock Option Plans On August 23, 2021, all vested and unvested options outstanding for Group Stock Option Plans were replaced by the ‘2021 Stock Entitlement Program’ of the Company (Holding Company Stock Option Plans) with similar terms as per the original options. The employees of the Group were entitled to 0.8289 Holding Company Stock Option for every one Group Stock Option held for both vested and unvested options with no changes in vesting period and exercise period. The exercise price of Group Stock Option, which was fixed in INR, got converted into US Dollars using exchange rate as on the date of replacement, as exercise price of Holding Company Stock Option. The Holding Company Stock Option Plans granted to the employees will be settled in Class A share of the Company. Therefore, the Holding Company Stock Option Plans have been classified as an equity settled share based payment. The replacement of Group Stock Option Plans with Holding Company Stock Option Plans is identified as replacement plan and accounted for as a modification of the Group Stock Option Plans. ESOP expenses [grant date fair value as per Group Stock Option Plans plus incremental fair value (if any) measured at the date of replacement] related to employees of the Group are recognised as employees’ expenses, over vesting period. The modification reduces the fair value of the stock options granted, measured immediately before and after the modification, and therefore the Group has not taken into account that decrease in fair value and had continued to measure the amount recognised for services received based on the grant date fair value of the Group Stock Option Plans granted. Pursuant to replacement of stock options, on the date of replacement, 6,933,865 vested and 7,146,270 unvested option of Group Stock Option Plans got replaced with 5,747,481 vested and 5,923,543 unvested Holding Company Stock Option Plans. The fair value of stock options was estimated at the date of replacement using Black-Scholes valuation model, taking into account the terms and conditions upon which the share options were granted. Following are the assumptions used in valuation of Holding Company Stock Option Plan as on the date of replacement:
|
|
|
|
|
Particulars |
|
Group Stock Option Plans |
|
Holding Company Stock Option Plans |
Dividend yield (%) |
|
0.0% |
|
0.0% |
Expected volatility (%) |
|
25.67% - 37.87% |
|
33.43% - 49.97% |
Risk–free interest rate (%) |
|
3.29% - 6.39% |
|
0.05% - 1.03% |
Weighted average expected life of options granted |
|
0.07 years - 6.86 years |
|
0.07 years - 6.86 years |
Weighted average share price |
|
INR 606.96 |
|
USD 8.17 |
The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome. The relevant terms of the Holding Company Stock Option Plans are as below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Holding Company Stock Option Plans |
Particulars |
2018 Stock Option Plan Modified |
|
2018 Stock Option Plan |
|
2017 Stock Option Plan |
|
2016 Stock Option Plan |
|
2014 Stock Option Plan |
|
2011 Stock Option Plan |
Grant date |
August 16, 2019 |
|
Multiple |
|
Multiple |
|
Multiple |
|
Multiple |
|
Multiple |
Replacement date |
August 23, 2021 |
|
August 23, 2021 |
|
August 23, 2021 |
|
August 23, 2021 |
|
August 23, 2021 |
|
August 23, 2021 |
Vesting period |
Time linked vesting: Grants will vest in 5 years on quarterly basis which shall commence one year after the date of original grant of options. |
|
Time linked vesting: 50 % of grants will vest in 5 years as follows: i) One year from the date of original grant, the Options for the first four quarters shall vest immediately. ii) Thereafter, vesting will continue on a quarterly basis for the unvested Options. Remaining 50% will vest at the end of 5 years from the date of original grant. |
|
Time linked vesting: 50 % of grants will vest in 5 years as follows: i) One year from the date of original grant, the Options for the first four quarters shall vest immediately. ii) Thereafter, vesting will continue on a quarterly basis for the unvested Options. Remaining 50% will vest at the end of 5 years from the date of original grant. |
|
Time linked vesting: 5 years on quarterly basis effective from December 1, 2015 on completion of one year from the date of original grant, the Options for the first seven quarters shall vest immediately. Thereafter, vesting will continue on quarterly basis for the unvested Options commencing from December 1, 2017.
Performance linked vesting: The Options shall vest annually and shall be prorated over a period of 3 years from the date of grant and shall be subject to the EBITDA achieved by the Company for the last completed financial year. The vesting of the Options shall take place at the end of the first anniversary of the date of original grant (Vesting date) and thereafter on March 31, 2018 and March 31, 2019 or at a later date when the audited financial statements of RPL are available. |
|
Time linked vesting: 5 years on quarterly basis which shall commence one year after the date of original grant of option. |
|
Time linked vesting: 5 years from the original grant date. |
|
|
|
|
|
|
|
|
|
|
|
|
Exercise period |
Within 10 years from the date of original grant upon vesting |
Exercise price |
USD 5.33 |
|
USD 5.33, 5.53 and 5.60 |
|
USD 4.53 |
|
USD 2.73 |
|
USD 1.75 |
|
USD 1.33 |
Settlement type |
Equity settled |
Expiry date |
August 16, 2029 |
|
April 24, 2028 to December 31, 2030 |
|
April 10, 2027 to February 25, 2028 |
|
September 30, 2026 |
|
December 31, 2022 to January 1, 2025 |
|
September 30, 2021 to December 31, 2022 |
Number of options outstanding as at (in million):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
1 |
|
|
|
1 |
|
|
|
7 |
|
|
|
1 |
|
|
|
1 |
|
|
|
1 |
|
March 31, 2024 |
|
1 |
|
|
|
1 |
|
|
|
7 |
|
|
|
1 |
|
|
|
1 |
|
|
|
1 |
|
The details of options outstanding are summarized below:
|
|
|
|
|
|
|
|
Particulars |
|
Number of options (in million) |
|
Outstanding as at April 1, 2022 |
|
|
12 |
|
Exercised / lapsed during the year |
|
|
1 |
|
Outstanding as at March 31, 2023 |
|
|
11 |
|
Exercised / lapsed during the year |
|
|
0 |
|
Outstanding as at March 31, 2024 |
|
|
11 |
|
Exercised / lapsed during the year |
|
|
0 |
|
Outstanding as at March 31, 2025 |
|
|
11 |
|
|
|
|
|
|
|
|
Exercisable as at March 31, 2024 |
|
|
11 |
|
Exercisable as at March 31, 2025 |
|
|
11 |
|
|
|
|
- |
The weighted average exercise price of these options outstanding was USD 4.20 for the period ended March 2025 (March 31,2024: USD 4.20). |
|
|
- |
The weighted average exercise price of exercisable options was USD 4.20 for the year ended March 31, 2025 (March 31, 2024: USD 4.20). |
|
|
- |
The weighted average exercise price of replacement of Group Stock Option Plans was USD 4.20 for the year ended March 31, 2025 (March 31, 2024: USD 4.20) |
|
|
- |
The weighted average exercise price of options exercised during the year was USD 4.13 for year ended March 31, 2025 (March 31, 2024: USD 2.15) |
|
|
- |
The weighted average remaining contractual life of options outstanding as at March 31, 2025 was 2.06 years (March 31, 2024: 2.97 years) |
|
|
- |
There were 17,254 options exercised during the year ended March 31, 2025 (March 31, 2024: 148,638 options) |
|
b)2021 Incentive Award Plan granted during the period August 23, 2021 to March 31, 2025 The Company introduced the 2021 Incentive Award Plan (Incentive Plan) to grant options to selected employees of the Group. The relevant terms of the Incentive Plan are as below: According to this scheme, the employees selected by the compensation committee from time to time will be entitled to options as per grant letter issued by the compensation committee, subject to satisfaction of prescribed vesting conditions. The employees will be issued class A equity share of the Company on exercises of this incentive plan.
|
|
|
|
|
|
|
|
|
Particulars |
2021 Incentive Plan |
Grant date |
February 10, 2025 |
October 23, 2024 |
August 23, 2024 |
May 24, 2024 |
May 15, 2024 |
April 10, 2024 |
April 1, 2024 |
April 1, 2024 |
Vesting period |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria. |
12.5% shares to vest on last day of each quarter starting from Sep 2023 until entire subsequent option grant gets vested. |
Restricted Stock Units (RSUs) On the 1st anniversary of the Grant Date - 33%; On the 2nd anniversary of the Grant Date – 33%; On the 3rd anniversary of the Grant Date – 34%
Performance Based Units (PBUs) On the 3rd anniversary of the Grant Date – 100% subject to achievement of Performance Metrics |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria. |
Restricted Stock Units (RSUs) On the 1st anniversary of the Grant Date - 33%; On the 2nd anniversary of the Grant Date – 33%; On the 3rd anniversary of the Grant Date – 34%
Performance Based Units (PBUs) On the 3rd anniversary of the Grant Date – 100% subject to achievement of Performance Metrics |
Restricted Stock Units (RSUs) On the 1st anniversary of the Grant Date - 33%; On the 2nd anniversary of the Grant Date – 33%; On the 3rd anniversary of the Grant Date – 34%
Performance Based Units (PBUs) On the 3rd anniversary of the Grant Date – 100% subject to achievement of Performance Metrics |
Exercise period |
Within 10 years from the date of grant upon vesting |
Within 8 years from date of grant upon vesting |
Within 10 years from the date of grant upon vesting |
Within 8 years from date of grant upon vesting |
Exercise price |
USD 6.38 |
USD 5.95 |
USD 10 |
USD 0.0001 |
USD 6.06 |
USD 6.84 |
USD 0.0001 |
USD 0.0001 |
Settlement type |
Equity Settled |
Expiry date |
February 10, 2035 |
October 23, 2034 |
August 23, 2034 |
May 24, 2032 |
May 15, 2034 |
April 10, 2034 |
April 1, 2032 |
April 1, 2032 |
Number of options outstanding as at (in million):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
0 |
|
|
0 |
|
|
4 |
|
RSU- 0 PBU- 0 |
|
|
4 |
|
|
4 |
|
RSU- 0 PBU- 0 |
|
RSU- 1 PBU- 0 |
|
March 31, 2024 |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
|
|
|
|
|
|
|
|
Particulars |
2021 Incentive Plan |
Grant date |
February 15, 2024 |
November 1, 2023 |
October 27, 2023 |
September 13, 2023 |
September 13, 2023 |
August 23, 2023 |
July 7, 2023 |
June 5, 2023 |
Vesting period |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
Restricted Stock Units (RSUs) On the 1st anniversary of the Grant Date - 33%; On the 2nd anniversary of the Grant Date – 33%; On the 3rd anniversary of the Grant Date – 34%
Performance Based Units (PBUs) On the 3rd anniversary of the Grant Date – 100% subject to achievement of Performance Metrics. |
12.5% shares to vest on last day of each quarter starting from Septemner 2023 untill entire subsequent option grant gets vested. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
Exercise period |
Within 10 years from the date of grant upon vesting |
Within 8 years from date of grant upon vesting |
Within 10 years from the date of grant upon vesting |
Exercise price |
USD 6.84 |
USD 5.78 |
USD 5.34 |
USD 5.87 |
USD 0.0001 |
USD 10.00 |
USD 5.48 |
USD 5.34 |
Settlement type |
Equity Settled |
Expiry date |
February 15, 2034 |
November 1, 2033 |
October 27, 2033 |
September 13, 2033 |
August 22, 2031 |
August 23, 2033 |
July 7, 2033 |
June 5, 2033 |
Number of options outstanding as at (in million):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
0 |
|
|
0 |
|
|
1 |
|
|
9 |
|
RSUs- 1; PBUs- 1 |
|
4 |
|
|
0 |
|
|
0 |
|
March 31, 2024 |
|
0 |
|
|
0 |
|
|
1 |
|
|
9 |
|
RSUs- 1; PBUs- 1 |
|
4 |
|
|
0 |
|
|
0 |
|
|
|
|
|
|
|
|
|
Particulars |
2021 Incentive Plan |
Grant date |
March 15, 2023 |
November 15, 2022 |
September 15, 2022 |
August 22, 2022 |
June 10, 2022 |
August 23, 2021, November 15, 2021 and March 15, 2022 |
August 23, 2021 |
Vesting period |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
12.5% of stock options will vest at the end of each quarter over a period of 2 years in a time based manner. |
Grant 1 80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's Performance criteria. Grant 2 80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 10% of stock options will vest at every anniversary of the grant date based on Company's Performance criteria |
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter). In addition, out of the remaining 20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance. |
6.25% of stock options will vest at the end of each quarter over a period of 4 years in a time based manner. |
Exercise period |
Within 10 years from the date of grant upon vesting |
Exercise price |
USD 5.85 |
USD 6.83 |
USD 10.00 |
USD 10.00 |
USD 10.00 |
USD 10.00 |
USD 10.00 |
Settlement type |
Equity Settled |
Expiry date |
March 15, 2033 |
November 15, 2032 |
September 15, 2032 |
August 23, 2032 |
June 10, 2032 |
August 23, 2031 to February 23, 2032 |
August 23, 2031 |
Number of options outstanding as at (in million):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
0 |
|
|
0 |
|
|
0 |
|
|
4 |
|
|
1 |
|
|
6 |
|
|
23 |
|
March 31, 2024 |
|
0 |
|
|
1 |
|
|
0 |
|
|
4 |
|
|
1 |
|
|
7 |
|
|
23 |
|
The fair value of stock options was estimated using Black-Scholes valuation model, taking into account the terms and conditions upon which the share options were granted. Following are the assumptions used in valuation of 2021 Incentive Award Plan:
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
2021 Incentive Award Plan |
|
2024 |
|
2025 |
Dividend yield (%) |
|
0.0% |
|
0.0% |
Expected volatility (%) |
|
25.68% to 41.23% |
|
28.52% to 33.90% |
Risk–free interest rate (%) |
|
0.78% to 5.42% |
|
3.64% to 5.21% |
Weighted average expected life of options granted |
|
8 to 10 years |
|
8 to 10 years |
Weighted average share price |
|
USD 4.98 to USD 9.65 |
|
USD 5.22 to USD 7.46 |
The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome. The details of options outstanding are summarized below:
|
|
|
|
|
|
|
|
Particulars |
|
Number of options (in million) |
|
Outstanding as at April 1, 2022 |
|
|
30 |
|
Granted during the year |
|
|
6 |
|
Exercised / lapsed during the year |
|
|
0 |
|
Outstanding as at March 31, 2023 |
|
|
36 |
|
Granted during the year |
|
|
16 |
|
Lapsed during the year |
|
|
|
|
|
1 |
|
Outstanding as at March 31, 2024 |
|
|
51 |
|
Granted during the year |
|
|
7 |
|
Lapsed during the year |
|
|
1 |
|
Outstanding as at March 31, 2025 |
|
|
57 |
|
|
|
|
|
|
|
|
Exercisable as at March 31, 2025 |
|
|
40 |
|
Exercisable as at March 31, 2024 |
|
|
25 |
|
|
|
- |
The weighted average exercise price of these options outstanding was USD 8.56 for the year ended March 31, 2025 (March 31, 2024: USD 8.81) |
|
|
- |
The weighted average exercise price of these options granted was USD 7.15 for the year ended March 31, 2025 (March 31, 2024: USD 6.36) |
|
|
- |
The weighted average exercise price of exercisable options was USD 9.47 for the year ended March 31, 2025 (March 31, 2024: USD 9.97) |
|
|
- |
The weighted average remaining contractual life for the share options outstanding as at March 31, 2025 was 7.27 years (March 31, 2024: 8.14 years). |
|
|
- |
There were 121,299 options (March 31, 2024: Nil) exercised during the year. |
c)Expenses arising from share-based payment transactions The expense recognised for employee services received during the year is shown in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
Particulars |
|
|
|
|
|
|
2023 |
|
|
2024 |
|
|
2025 |
|
Expense arising from equity-settled share-based payment transactions |
|
|
2,512 |
|
|
|
2,278 |
|
|
|
2,402 |
|
Total expense arising from share-based payment transactions* |
|
|
2,512 |
|
|
|
2,278 |
|
|
|
2,402 |
|
* This amount is inclusive of amount capitalised in different projects.
|